Major equity indexes are already approaching “washed-out territory.” Investors with a long-term investing horizon should ...

This stands to reason, as nearly every stage of drug development and marketing is resource- and capital-intensive, and as a ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Retail investors bought $4.7 billion in stocks on Thursday, the highest level over the past decade, JPMorgan said in a note ...

With the stock market going through a downturn due to uncertainties about how tariffs will (or won't) affect the economy, ...

When in doubt about your next best bet, consider poaching an idea (or three) from the world's most proven stock picker.

The company doesn’t directly benefit from tariffs. Instead, the stock benefits from the disruptions tariffs are going to ...

Jim Cramer continues to see buying opportunities amidst market sell-off. Here's why he is bullish on NVDA, AMZN, and HD ...

The stock has a 3.3% dividend yield, and the company boasts 40 consecutive years of dividend increases. Clorox is a good buy ...

Even if tariffs don’t lead to a recession, investors still need to be wary because inventories are too high, especially ...

The saying, it takes money to make money also used to be the rule on Wall Street, but not any more thanks to the ...